What do the arrows in the Musée du quai Branly collection reveal about Indigenous culture and design evolution? These artifacts, numbering 115 and dating back to the 1700s, provide a unique glimpse into the craftsmanship and materials used by Indigenous peoples in the Southeast and Central U.S.
Most arrows in this collection are lightweight with thin shafts, contrasting sharply with later Choctaw arrows, which are characterized by their thick and heavy construction. Made from materials such as river cane, hardwood, garfish scales, and deer antler, these arrows were likely intended for hunting small game, as indicated by their design.
Notably, some arrows in the collection exhibit teeth marks from the maker, who straightened them in his mouth approximately 300 years ago. This detail underscores the human element behind these artifacts, as noted by experts who emphasize that “the arrows in this collection hold neat human details.”
Importantly, the collection predates the Trail of Tears, offering a rare opportunity to study the cultural practices of Indigenous peoples before significant historical upheaval. The arrows also include only a few with metal tips, reflecting the materials available at the time.
In a different context, the term “arrow” is also associated with recent advancements in medical research. The final data from the ARROW study indicates robust and durable responses to pralsetinib in patients with RET fusion-positive non-small cell lung cancer (NSCLC). This targeted therapy is designed to selectively address RET alterations in metastatic NSCLC and advanced thyroid carcinoma.
Dr. Justin F. Gainor highlighted that the ARROW study shows a manageable safety profile for pralsetinib, while Dr. Lisa Rojkjaer stated, “These longer-term data further support pralsetinib’s role as a first-line treatment option for RET fusion-positive NSCLC patients.”
The importance of early biomarker testing for RET fusion-positive NSCLC is emphasized in the study’s findings, which follow 42 months of patient follow-up.
As research continues, the implications of both the historical arrows and the medical advancements remain significant. The arrows in the Branly collection serve as a testament to Indigenous ingenuity, while the ARROW study reflects ongoing efforts to improve cancer treatment.
Details remain unconfirmed regarding future exhibitions of the arrow collection or additional findings from the ARROW study, leaving both historical and medical communities eager for further insights.
